Artemis Medicare Services Limited has taken a significant step in strengthening its capital structure by allotting 1.89 crore equity shares to the International Finance Corporation (IFC). This move comes as a result of the conversion of compulsorily convertible debentures (CCDs), marking a notable development in the company's financial landscape.

Key Details of the Allotment

• Shares Allotted: 1,89,62,247 equity shares
• Recipient: International Finance Corporation (IFC)
• Conversion Basis: 33,000 compulsorily convertible debentures
• Conversion Price: Rs. 174.03 per share
• Face Value of New Shares: Re. 1 each

Impact on Share Capital

The allotment has resulted in a significant increase in Artemis Medicare's paid-up equity share capital:

This expansion represents a 13.62% increase in the company's equity base.

Debenture Details

The converted debentures had the following characteristics:

• Number of CCDs: 33,000
• Face Value: Rs. 1,00,000 each
• Interest Rate: 2.65% per annum, compounded quarterly on a cumulative basis

Regulatory Compliance and Trading

The allotment adheres to SEBI regulations, particularly the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The newly issued shares will rank pari passu with existing equity shares and are set to be listed and traded on both the BSE Limited and the National Stock Exchange of India Limited, pending necessary approvals.

Strategic Implications

This conversion of debentures into equity represents a strategic move for Artemis Medicare. By bringing IFC, a reputed international financial institution, into its equity fold, the company may be positioning itself for potential growth and expansion. The increased equity base could provide more financial flexibility and potentially enhance the company's ability to pursue its business objectives.

Conclusion

The allotment of shares to IFC through the conversion of CCDs marks a significant corporate action for Artemis Medicare Services Limited. As the company's equity base expands, stakeholders will be keen to observe how this capital infusion influences the company's future strategies and financial performance in the healthcare sector.

Artemis Medicare Services Limited , a leading healthcare provider, has announced robust financial results for the second quarter of fiscal year 2026, demonstrating significant growth across key metrics.

Financial Highlights

For Q2 FY26, Artemis Medicare reported:

• Consolidated revenue from operations of Rs 274.70 crore, up 13.8% year-over-year (YoY)
• EBITDA of Rs 58.27 crore, a 17.2% increase YoY
• Net profit after tax (PAT) of Rs 30.00 crore, surging 35.6% YoY
• EBITDA margin improved to 21.2% from 20.6% in Q2 FY25

Operational Performance

The company's flagship hospital in Gurugram showed strong operational metrics:

• Average Revenue Per Occupied Bed (ARPOB) increased to Rs 81,248, up 7.4% YoY
• Inpatient volumes grew by 9.0% YoY to 8,740
• Bed occupancy rate stood at 64.1%
• Revenue from overseas patients rose by 30.1% to Rs 82.49 crore, contributing 32% to net revenue

Half-Yearly Performance

For H1 FY26, Artemis Medicare's consolidated results included:

• Revenue from operations of Rs 529.66 crore, up 14.0% YoY
• EBITDA of Rs 106.60 crore, growing 18.1% YoY
• PAT of Rs 51.20 crore, a substantial increase of 32.5% YoY

Management Commentary

Onkar Kanwar, Chairman of Artemis Medicare Services Ltd, stated, "We are pleased to report another quarter of steady progress, building on the strong momentum of FY26. In Q2, we continued to deliver healthy growth and robust operational performance, driven by disciplined execution, cost optimization, and a sustained focus on clinical and service excellence."

He added, "Our profitability and margins remained resilient, supported by an improved case and payor mix, higher international patient volumes, and continued operational efficiency. ARPOB remained at elevated levels during the quarter, reaffirming our strong positioning in high-acuity care and Medical Value Travel."

Expansion Plans

The company is progressing with its expansion initiatives:

• The ramp-up of newly added beds at the flagship hospital's third tower is expected to contribute to growth in the coming quarters.
• Artemis is on track to operationalize its upcoming 300+ bed super-specialty hospital in Raipur, Chhattisgarh, by March 2026.

Financial Position

As of September 30, 2025, Artemis Medicare maintained a strong balance sheet with:

• Total shareholders' funds of Rs 888.48 crore
• Cash and bank balances of Rs 348.09 crore

The company's focus on sustainable growth through operational excellence, network expansion, and strategic partnerships positions it well for future success in India's growing healthcare sector.